Fayez Sarofim & CO Merck & Co., Inc. Transaction History
Fayez Sarofim & CO
- $41.7 Billion
- Q3 2025
A detailed history of Fayez Sarofim & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 2,406,322 shares of MRK stock, worth $223 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
2,406,322
Previous 2,620,725
8.18%
Holding current value
$223 Million
Previous $207 Million
2.65%
% of portfolio
0.48%
Previous 0.52%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,877Shares Held
1.9BCall Options Held
31.1MPut Options Held
28.5M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...